Management of gastrointestinal stromal tumours in the Imatinib era: a surgeon's perspective (original) (raw)

Gastrointestinal Stromal Tumors: Case Series of 29 Patients Defining the Role of Imatinib Prior to Surgery

Supreeta Arya

2012

View PDFchevron_right

A Guideline for the Management of Gastrointestinal Stromal Tumour (GIST)

Martin Robinson

Sarcoma, 2002

View PDFchevron_right

Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients

Jan Andersson

British journal of cancer, 2003

View PDFchevron_right

The role of surgery in the management of gastrointestinal stromal tumors (GISTs) in the era of imatinib mesylate effectiveness

Evangelos Efstathios Visvardis

Surgical Oncology, 2005

View PDFchevron_right

Surgical Resection of Gastrointestinal Stromal Tumors After Treatment with Imatinib

Michael Burgess

Annals of Surgical Oncology, 2007

View PDFchevron_right

SURGERY FOR GASTROINTESTINAL STROMAL TUMOUR IN THE POST-IMATINIB ERA

susan neuhaus

Anz Journal of Surgery, 2005

View PDFchevron_right

Current management of gastrointestinal stromal tumors – A comprehensive review

Dr. Naveen Solanki

International Journal of Surgery, 2012

View PDFchevron_right

Surgical Treatment of Gastrointestinal Stromal Tumors Located in the Stomach in the Imatinib Era

Annemieke Cats

American Journal of Clinical Oncology, 2013

View PDFchevron_right

Imatinib and gastrointestinal stromal tumor (GIST): a selective targeted therapy

JORGE APARICIO

Revista Espanola De Enfermedades Digestivas, 2004

View PDFchevron_right

GENERAL CHARACTERISTICS AND TREATMENT OPTIONS OF THE PATIENTS WITH GASTROINTESTINAL STROMAL TUMOR

National Journal of Medical Research

National Journal of Medical Research, 2013

View PDFchevron_right

Profile of patients with gastrointestinal stromal tumors (GIST)

Eduardo Pracucho

ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), 2015

View PDFchevron_right

Gastrointestinal stromal tumours: Clinical overview, surgery and recent advances in imatinib mesylate therapy

G.eorges F Samelis

European Journal of Surgical Oncology (EJSO), 2007

View PDFchevron_right

Imatinib as adjuvant treatment following resection of KIT-positive gastrointestinal stromal tumours

Claire Hulme

Health technology assessment (Winchester, England), 2010

View PDFchevron_right

Gastrointestinal stromal tumour treated with neoadjuvant imatinib

Paul Waring

Journal of Clinical Pathology, 2005

View PDFchevron_right

Optimizing Tyrosine Kinase Inhibitor Therapy in Gastrointestinal Stromal Tumors: Exploring the Benefits of Continuous Kinase Suppression

Axel Le Cesne, J.- Y. Blay

The Oncologist, 2013

View PDFchevron_right

Nationwide trends in the incidence and outcome of patients with gastrointestinal stromal tumour in the imatinib era

J. Bonenkamp

British Journal of Surgery

View PDFchevron_right

One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor A Randomized Trial

Kirsten S Hall

JAMA: The Journal of the American Medical Association, 2012

View PDFchevron_right

Consensus meeting for the management of gastrointestinal stromal tumors * Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO

Joan Maurel, George Demetri

Annals of Oncology, 2005

View PDFchevron_right

NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines

Maria Debiec-Rychter

Journal of the National Comprehensive Cancer Network, 2007

View PDFchevron_right

Real-World Evidence of Patient Outcome Following Treatment of Advanced Gastrointestinal Stromal Tumor (GIST) with Imatinib, Sunitinib, and Sorafenib in Publicly Funded Health Care in Poland

Melania Brzozowska

Medical Science Monitor, 2019

View PDFchevron_right

Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial

Giuliano Ramadori

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015

View PDFchevron_right

NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors

Robert Maki

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

View PDFchevron_right

Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates

Robin L Jones

Current Treatment Options in Oncology

View PDFchevron_right

The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours

Amitesh Roy

Targeted Oncology

View PDFchevron_right

Gastrointestinal stromal tumors in the imatinib era: 15 years' experience of a tertiary center

Guilherme Macedo

Journal of gastrointestinal oncology, 2018

View PDFchevron_right

Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience

Paweł Nyckowski

Annals of Surgical Oncology, 2013

View PDFchevron_right

Treatment of non-resectable and metastatic gastrointestinal stromal tumors: experience with the use of tyrosine kinase inhibitors in a third level hospital in Mexico

Samuel Rivera

Journal of Gastrointestinal Oncology, 2016

View PDFchevron_right

Treatment of gastrointestinal stromal tumors--initial experience

Cristian Lupascu

Chirurgia (Bucharest, Romania : 1990)

View PDFchevron_right